• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of external presentations to Societies, Consortia, Industrial and Government administered by OBP staff within the month

Dictionary: The Office of Biotechnology Products (OBP) has laboratories that perform research in areas that inform review and policy for OBP products. These areas include manufacturing science (e.g. Quality by Design, Process Analytical technology, Viral Safety), structural characterization, biological characterization (Potency Bioassays, Mechanisms of Action, Biological Models) and linking quality to safety and efficacy (Immunogenicity, Epidemiology). Our presentations and publications reflect work in these areas.


This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Oct 2009N/A9
Nov 2009N/A10
Dec 2009N/A0
Jan 2010N/A21
Feb 2010N/A4
Mar 2010N/A8
Apr 2010N/A7
May 2010N/A19
Jun 2010N/A13
Jul 2010N/A14
Aug 2010N/A4
Sep 2010N/A15

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.